Achim Schäffler
Corporate Officer/Principal bei Horizon Therapeutics GmbH
Ursprung des Netzwerks ersten Grades von Achim Schäffler
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
35
| Public Company | Pharmaceuticals: Major | 35 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
28
| College/University | Other Consumer Services | 28 |
Ruprecht-Karls-Universität Heidelberg
26
| College/University | Other Consumer Services | 26 |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Achim Schäffler
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| FRESENIUS SE & CO. KGAA | Medical Specialties | Director/Board Member Sales & Marketing Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal | |
| POXEL | Pharmaceuticals: Major | Founder Founder Founder Corporate Officer/Principal | |
| SIEMENS AG | Industrial Machinery | Compliance Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VOLKSWAGEN AG | Motor Vehicles | Director/Board Member Corporate Officer/Principal Director/Board Member | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Comptroller/Controller/Auditor | |
| Eberhard Karls Universität Tübingen | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Executive Officer Director of Finance/CFO Comptroller/Controller/Auditor | |
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| FRAPORT AG | Other Transportation | Director/Board Member Director/Board Member Director/Board Member | |
| Hoechst Marion Roussel, Inc. | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | ||
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing Corporate Officer/Principal | |
| Verein angestellter Akademiker und leitender Angestellter der | Corporate Officer/Principal Corporate Officer/Principal | ||
CEVEC Pharmaceuticals GmbH
 CEVEC Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| VIVESTO AB | Pharmaceuticals: Generic | Chairman Director/Board Member | |
| Aventis Pharma AG | Corporate Officer/Principal Corporate Officer/Principal | ||
thyssenkrupp Steel Europe AG
 thyssenkrupp Steel Europe AG SteelNon-Energy Minerals thyssenkrupp Steel Europe AG manufactures carbon steel, stainless steel, and special steel materials. Its products include hot and precision strips, heavy plates, sheet and coated products, organic coated strips and sheets, composite materials, electrical steel products, tinplates and black plates, and medium-wide strips. The company was founded in 1997 and is headquartered in Duisburg, Germany. | Steel | Director of Finance/CFO Director/Board Member | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BASF SE | Electrical Products | Corporate Officer/Principal Director/Board Member | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
| EVONIK INDUSTRIES AG | Chemicals: Major Diversified | Director/Board Member Corporate Officer/Principal | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member Chairman | |
| THYSSENKRUPP AG | Steel | Corporate Officer/Principal Director/Board Member | |
| Freie Universität Berlin | College/University | Graduate Degree Doctorate Degree | |
| SYMRISE AG | Chemicals: Specialty | Director of Finance/CFO Director/Board Member | |
| Technische Universität München | College/University | President Doctorate Degree | |
| ALTANA AG | Chemicals: Specialty | Corporate Officer/Principal Director/Board Member | |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Technical University of Berlin | College/University | Undergraduate Degree Doctorate Degree | |
| University of Freiburg | College/University | Doctorate Degree Graduate Degree | |
| University of Giessen | College/University | Undergraduate Degree Doctorate Degree | |
| BIOTEST AG | Pharmaceuticals: Other | Chairman Director/Board Member | |
| HOCHTIEF AG | Engineering & Construction | Director/Board Member Director/Board Member | |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor Private Equity Investor | |
| AFFIMED N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| CENTOGENE N.V. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree |
Statistik
International
| Deutschland | 31 |
| Vereinigte Staaten | 10 |
| Schweiz | 6 |
| Frankreich | 3 |
| Schweden | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 11 |
| Process Industries | 5 |
| Producer Manufacturing | 3 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 372 |
| Corporate Officer/Principal | 267 |
| Chairman | 74 |
| Chief Executive Officer | 67 |
| Independent Dir/Board Member | 62 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Regina Hodits | 34 |
| Elmar Schnee | 31 |
| Norbert Riedel | 29 |
| Hubert Birner | 27 |
| Karl Härfstrand | 23 |
| Elke Eller | 22 |
| David Smoller | 21 |
| Christopher Delbrück | 21 |
| Uwe Hans Reuter | 21 |
| Peter Johann | 18 |
| Lynne Sullivan | 16 |
| Cory Gossard | 16 |
| Karl Nägler | 16 |
| Uta Kemmerich-Keil | 16 |
| Bernhard R. M. Ehmer | 16 |
- Börse
- Insiders
- Achim Schäffler
- Unternehmensverbindungen
